UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62
Here's Why American Healthcare REIT (AHR) is Poised for a Turnaround After Losing 7.8% in 4 Weeks
Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
American Healthcare REIT: A Dip Buy Driven By Senior-Care And Outpatient Tailwind
American Healthcare REIT Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
3 Equity REIT Stocks Worth Betting on Despite Industry Headwinds
American Healthcare REIT Declares Third Quarter 2026 Distribution
American Healthcare REIT (AHR) Raised $819 Million, Is The Upside Already Priced In?
Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?
American Healthcare REIT, Inc. (AHR) Presents at BofA NY Global Real Estate Conference 2026 Transcript
American Healthcare REIT Publishes 2025 Corporate Responsibility Report
American Healthcare REIT to Participate at BofA Securities 2026 Global Real Estate Conference
American Healthcare REIT Names Ann Lacey Executive Vice President, Asset Management – Senior Housing
American Healthcare REIT Executive Sells 2,000 Shares for $111,000
Pump The Brakes On American Healthcare REIT
American Healthcare REIT Names Jon Crosier Chief Technology Officer
American Healthcare REIT Acquires Eight Senior Housing Communities for $696 Million, Establishing East Coast Platform and New Partnership with LCB Senior Living
American Healthcare REIT Acquires 8 Class A Senior Housing Communities For Approximately $696M, Establishing A New Operating Relationship With LCB Senior Living And A Substantial Presence In Supply-constrained East Coast Markets
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.